Phosphate Buffer Saline (PBS) and Tris Buffer Saline (TBS) are concentrated wash solutions designed for rinsing reagents from tissue slides and preserving tissue sections between reagent applications. PBS is recommended with any detection system, except those containing alkaline phosphatase. Conversely, TBS is recommended when alkaline phosphatase is present to avoid excessive phosphate accumulation and consequent reduction in the rate of reaction. Adding Tween® 20 to both PBS and TBS may help reduce background and produce a cleaner immunohistochemical stain overall. The most significant factor is the intention for use to visualize the stain, with what chromogen and detection kit. For HRP or Alk Phos on the breast panel, TBS can be used for both. For diluent, as long as products are stored properly (2 to 8C), the diluent will help stabilize diluted antibodies, and the same applies for use with HRP or Alk Phos detection for TBS to be run on either, while PBS works best with HRP. This allows for a longer expiration date and aligns with the antibody expiration date.
935B
TBS IHC Wash Buffer + TWEEN® 20
20X TBS, 1% Tween® 20
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
| 容量 | カタログ番号 | 在庫状況 | 単価 |
|---|
この商品について
NACRES:
NA.24
UNSPSC Code:
12352200
現在、価格および在庫状況を閲覧できません。
General description
Tris Buffered Immunohistochemistry wash buffer plus TWEEN 20 is a 20X concentrated solution that is employed to rinse reagents off slides and to provide a medium for short-term storage of immunohistochemistry specimens in between application of reagents.
Biochem/physiol Actions
Tween 20 helps in the enhancement of intestinal movement of doxorubicin in vitro but not in vivo.
Physical form
Solution containing TBS buffer and TWEEN 20
Other Notes
For Technical Service please contact: 800-665-7284 or email: [email protected]
Legal Information
TWEEN is a registered trademark of Croda International PLC
保管分類
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
関連コンテンツ
Tween 20 increases intestinal transport of doxorubicin in vitro but not in vivo.
Al-Saraf A, et al.
International Journal of Pharmaceutics, 498(1-2), 66-69 (2016)